Published in J Pediatr Gastroenterol Nutr on December 01, 2011
Pediatric vascular tumors of the liver: beware! J Pediatr Gastroenterol Nutr (2011) 0.75
Diffuse Infantile Hepatic Hemangioendothelioma With Early Central Enhancement in an Adult: A Case Report of CT and MRI Findings. Medicine (Baltimore) (2015) 0.75
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology (2006) 5.46
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A (2010) 2.91
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J (2013) 2.70
miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol (2008) 2.61
[Clinical practice guidelines on the use of liver biopsy]. Gastroenterol Clin Biol (2002) 2.22
Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology (2005) 2.13
Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci U S A (2006) 2.08
Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology (2004) 1.98
Anaerobic digestion of microalgae as a necessary step to make microalgal biodiesel sustainable. Biotechnol Adv (2009) 1.94
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell (2008) 1.70
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. Transplantation (2003) 1.65
Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening. Pediatrics (2009) 1.62
Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism? Am J Med Genet A (2005) 1.61
Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol (2010) 1.60
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol (2013) 1.58
Wilson disease in offspring of affected patients: report of four French families. Clin Res Hepatol Gastroenterol (2013) 1.53
Corynebacterium ulcerans in an immunocompromised patient with diphtheria and her dog. J Clin Microbiol (2005) 1.53
Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol (2003) 1.51
MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease. Hepatology (2014) 1.48
Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr (2002) 1.47
Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms. Blood (2009) 1.47
Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab (2004) 1.46
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology (2010) 1.44
Complications of congenital portosystemic shunts in children: therapeutic options and outcomes. J Pediatr Gastroenterol Nutr (2010) 1.44
Experience with endoscopic management of high-risk gastroesophageal varices, with and without bleeding, in children with biliary atresia. Gastroenterology (2013) 1.42
Transcriptional activation of interleukin-8 by beta-catenin-Tcf4. J Biol Chem (2002) 1.40
Portopulmonary Hypertension in Liver Disease Presenting in Childhood. J Pediatr Gastroenterol Nutr (2015) 1.40
Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis (2009) 1.38
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis (2010) 1.38
Life-cycle assessment of biodiesel production from microalgae. Environ Sci Technol (2009) 1.36
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol (2011) 1.25
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics (2004) 1.23
Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr (2004) 1.23
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology (2003) 1.22
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab (2004) 1.19
Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology (2002) 1.17
Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer (2005) 1.16
Heterozygous bile salt export pump deficiency: a possible genetic predisposition to transient neonatal cholestasis. J Pediatr Gastroenterol Nutr (2006) 1.16
CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr (2002) 1.14
Management of patients with biliary atresia in France: results of a decentralized policy 1986-2002. Hepatology (2006) 1.13
Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology (2004) 1.12
Improving outcomes of biliary atresia: French national series 1986-2009. J Hepatol (2013) 1.12
Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. Gastroenterology (2009) 1.11
Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice. Nat Biotechnol (2002) 1.11
Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? Eur J Cancer (2011) 1.10
Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions. Gastrointest Endosc (2004) 1.09
A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature. Hepatology (2009) 1.06
Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study. Cancer (2002) 1.05
Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood (2004) 1.04
Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation. Hepatology (2006) 1.04
Influence of cycling cadence on subsequent running performance in triathletes. Med Sci Sports Exerc (2002) 1.03
Gastric inflammatory myofibroblastic tumors in children: an unpredictable course. J Pediatr Gastroenterol Nutr (2002) 1.02
A virtual imaging platform for multi-modality medical image simulation. IEEE Trans Med Imaging (2013) 1.00
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology (2012) 1.00
SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect. J Hepatol (2004) 0.99
Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2. J Hepatol (2012) 0.99
Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors. Blood (2006) 0.98
Acute liver failure in neonates, infants and children. Expert Rev Gastroenterol Hepatol (2011) 0.97
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection. Cancer (2012) 0.97
WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? Genes Chromosomes Cancer (2009) 0.96
Automated segmentation of a motion mask to preserve sliding motion in deformable registration of thoracic CT. Med Phys (2012) 0.96
IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report. J Pediatr Hematol Oncol (2008) 0.95
Modelling neutral lipid production by the microalga Isochrysis aff. galbana under nitrogen limitation. Bioresour Technol (2010) 0.95
Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. Clin Cancer Res (2006) 0.94
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature. Hepatology (2014) 0.94
Liver diseases related to MDR3 (ABCB4) gene deficiency. Front Biosci (Landmark Ed) (2009) 0.92
Peripancreatic paraganglioma: a potential diagnostic challenge in cytopathology and surgical pathology. Am J Surg Pathol (2011) 0.92
Rat hepatocytes express functional P2X receptors. FEBS Lett (2007) 0.92
Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl (2005) 0.91
Fusarium keratitis and endophthalmitis associated with lens contact wear. Int Ophthalmol (2009) 0.91
Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol (2012) 0.91
A pharmacogenetics study of the human glucuronosyltransferase UGT1A4. Pharmacogenet Genomics (2009) 0.91
Mitochondrial Infantile Liver Disease due to TRMU Gene Mutations: Three New Cases. JIMD Rep (2013) 0.91
Progressive familial intrahepatic cholestasis type 3 revealed by oral contraceptive pills. J Hepatol (2003) 0.91
Claudin-1 involved in neonatal ichthyosis sclerosing cholangitis syndrome regulates hepatic paracellular permeability. Hepatology (2012) 0.90